Treatment of polydipsia and hyponatremia in psychiatric patients can clozapine be a new option

Jose De Leon, Cherian Verghese, Joseph K. Starnila, Theodore Lawrence, George M. Simpson

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Polydipsia occurs frequently in chronic schizophrenic patients, some of whom develop intermittent hyponatremia. Most therapeutic efforts have tried to control the hyponatremia. Four schizophrenic patients, followed for more than one year, showed improvement on clozapine. Case 1 was an outpatient without history of hyponatremia who improved from polydipsia and psychosis. The last three were inpatients with polydipsia, intermittent hyponatremia, and psychosis who showed minimal improvement of psychosis but significant decrease in polydipsia and water intoxication. Case 2 relapsed to polydipsia when clozapine was discontinued on two occasions. Case 3 demonstrated polyuria during 39% of days before clozapine and in 0% of days after two weeks of clozapine. In case 4, most baseline sodium levels were abnormal, but all became normal after clozapine. A time-series analysis for intervention effects showed a significant effect of clozapine (p =. 017). The limited information provided by these case reports suggest the need for controlled studies of the clozapine effect on polydipsic patients.

Original languageEnglish
Pages (from-to)133-138
Number of pages6
JournalNeuropsychopharmacology
Volume12
Issue number2
DOIs
StatePublished - Apr 1995

Bibliographical note

Funding Information:
The authors are grateful to Marion Wilson, R.N., Sudhir Stokes, M.D., and to the staff of Haverford and Norristown State Hospital Research Units for their help with the patients. Ken H. Gilman and Robert Blake, medical students, were recipients of the Stanley Foundation Fellowship when they were working on this project. This study was partially supported by a PAL NIMH grant (MH 45190). Cherian Verghese, M.D. had additional support from a NARSAD grant.

Funding

The authors are grateful to Marion Wilson, R.N., Sudhir Stokes, M.D., and to the staff of Haverford and Norristown State Hospital Research Units for their help with the patients. Ken H. Gilman and Robert Blake, medical students, were recipients of the Stanley Foundation Fellowship when they were working on this project. This study was partially supported by a PAL NIMH grant (MH 45190). Cherian Verghese, M.D. had additional support from a NARSAD grant.

FundersFunder number
PAL NIMHMH 45190
National Alliance for Research on Schizophrenia and Depression

    Keywords

    • Case report
    • Clozapine
    • Hyponatremia
    • Schizophrenia
    • Thirst
    • Water intoxication

    ASJC Scopus subject areas

    • Pharmacology
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Treatment of polydipsia and hyponatremia in psychiatric patients can clozapine be a new option'. Together they form a unique fingerprint.

    Cite this